BDBM50166681 3-(5-{2-[N-(4,5-Dihydro-1H-imidazol-2-yl)-aminooxy]-ethoxy}-indol-1-yl)-3-phenyl-propionic acid::CHEMBL191518
SMILES: OC(=O)CC(c1ccccc1)n1ccc2cc(OCCONC3=NCCN3)ccc12
InChI Key: InChIKey=IYMCWAYNJYPRLE-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ITGAV/ITGB3 (Homo sapiens (Human)) | BDBM50166681 (3-(5-{2-[N-(4,5-Dihydro-1H-imidazol-2-yl)-aminooxy...) | PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents | Article PubMed | n/a | n/a | 200 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson& Johnson, Pharmaceutical Research and Development, L.L.C. Curated by ChEMBL | Assay Description Inhibitory concentration against alphaV-beta3 integrin | Bioorg Med Chem Lett 15: 2679-84 (2005) Article DOI: 10.1016/j.bmcl.2005.01.028 BindingDB Entry DOI: 10.7270/Q2N29Z40 | |||||||||||
More data for this Ligand-Target Pair |